Lastly, a recent clinical trial using rh‐IL‐7 as adjuvant therapy every 2 weeks combined with dendritic cell vaccination or autologous lymphocyte infusion led to significantly better OS in pediatric sarcoma patients compared to that of the patients in a historical control cohort.17 Here, IL7 is linked to sarcoma.